share_log

Nu Skin Enterprises Analyst Ratings

Benzinga ·  Aug 2, 2023 11:47
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
08/02/2023 25.09% Stifel $43 → $35 Maintains Hold
05/19/2023 35.81% DA Davidson → $38 Reiterates Neutral → Neutral
03/01/2023 46.53% Citigroup $35 → $41 Maintains Neutral
02/16/2023 35.81% DA Davidson $40 → $38 Maintains Neutral
01/31/2023 39.39% Jefferies → $39 Downgrades Buy → Hold
11/23/2022 21.52% DA Davidson $40 → $34 Maintains Neutral
10/05/2022 39.39% Citigroup $47 → $39 Maintains Neutral
08/23/2022 42.96% DA Davidson $45 → $40 Maintains Neutral
08/08/2022 67.98% Citigroup $45 → $47 Maintains Neutral
05/05/2022 60.83% DA Davidson $50 → $45 Maintains Neutral
02/17/2022 78.7% DA Davidson $47 → $50 Maintains Neutral
11/24/2021 75.13% Citigroup $43 → $49 Maintains Neutral
10/06/2021 67.98% DA Davidson $61 → $47 Maintains Neutral
02/12/2021 107.29% DA Davidson $71 → $58 Downgrades Buy → Neutral
02/02/2021 135.88% Jefferies $60 → $66 Maintains Buy
10/02/2020 143.03% DA Davidson $61 → $68 Maintains Buy
10/02/2020 B of A Securities Upgrades Underperform → Neutral
08/06/2020 96.57% Stifel $50 → $55 Maintains Hold
07/02/2020 92.99% DA Davidson $35 → $54 Upgrades Neutral → Buy
07/02/2020 78.7% Jefferies $42 → $50 Upgrades Hold → Buy
06/11/2020 28.66% Stifel $35 → $36 Maintains Hold
05/07/2020 3.65% Citigroup $25 → $29 Maintains Neutral
05/07/2020 25.09% Deutsche Bank $28 → $35 Maintains Hold
03/09/2020 0.07% Deutsche Bank $40 → $28 Downgrades Buy → Hold
02/14/2020 17.94% Citigroup $43 → $33 Maintains Neutral
02/13/2020 7.22% B of A Securities $40 → $30 Maintains Underperform
12/05/2019 53.68% Citigroup → $43 Assumes → Neutral
11/06/2019 Citigroup Downgrades Buy → Neutral
10/30/2019 Stifel Upgrades Sell → Hold
07/18/2019 85.85% Citigroup $86 → $52 Maintains Buy
07/17/2019 35.81% DA Davidson $88 → $38 Downgrades Buy → Neutral
05/01/2019 Deutsche Bank Upgrades Hold → Buy
03/25/2019 53.68% Stifel $63 → $43 Downgrades Hold → Sell
10/09/2018 228.81% DA Davidson → $92 Initiates Coverage On → Buy
08/03/2018 150.18% Stifel $57 → $70 Upgrades Sell → Hold

What is the target price for Nu Skin Enterprises (NUS)?

The latest price target for Nu Skin Enterprises (NYSE: NUS) was reported by Stifel on August 2, 2023. The analyst firm set a price target for $35.00 expecting NUS to rise to within 12 months (a possible 25.09% upside). 9 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for Nu Skin Enterprises (NUS)?

The latest analyst rating for Nu Skin Enterprises (NYSE: NUS) was provided by Stifel, and Nu Skin Enterprises maintained their hold rating.

When is the next analyst rating going to be posted or updated for Nu Skin Enterprises (NUS)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Nu Skin Enterprises, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Nu Skin Enterprises was filed on August 2, 2023 so you should expect the next rating to be made available sometime around August 2, 2024.

Is the Analyst Rating Nu Skin Enterprises (NUS) correct?

While ratings are subjective and will change, the latest Nu Skin Enterprises (NUS) rating was a maintained with a price target of $43.00 to $35.00. The current price Nu Skin Enterprises (NUS) is trading at is $27.98, which is out of the analyst's predicted range.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment